These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 33047719)

  • 1. [Association of
    Liu TF; Lin T; Ren LH; Li GP; Peng JJ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Oct; 52(5):856-862. PubMed ID: 33047719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Association between
    Liu TF; Lin T; Ren LH; Li GP; Peng JJ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Dec; 52(6):1082-1087. PubMed ID: 33331317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Association between CMTM5 gene rs723840 single nucleotide polymorphism and high on asprin platelet reactivity].
    Liu TF; Zhang JW; Chen XH; Feng XR; Bai ZS; Liu ML
    Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Dec; 47(6):905-9. PubMed ID: 26679648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of aspirin response-related transcripts in patients with coronary artery disease and preliminary investigation on CMTM5 function.
    Zhang JW; Liu TF; Chen XH; Liang WY; Feng XR; Wang L; Fu SW; McCaffrey TA; Liu ML
    Gene; 2017 Aug; 624():56-65. PubMed ID: 28457985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CMTM5 inhibits the development of prostate cancer via the EGFR/PI3K/AKT signaling pathway.
    Li L; Hu Y; Chen D; Zhu J; Bao W; Xu X; Chen H; Chen W; Feng R
    Mol Med Rep; 2022 Jan; 25(1):. PubMed ID: 34791506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of the Endothelial Nitric Oxide Synthase Gene T786C Polymorphism with In-Stent Restenosis in Chinese Han Patients with Coronary Artery Disease Treated with Drug-Eluting Stent.
    Zeng WP; Zhang R; Li R; Luo JF; Hu XF
    PLoS One; 2017; 12(1):e0170964. PubMed ID: 28129392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for revascularization and in-stent restenosis in patients with triple-vessel disease after second-generation drug-eluting stent implantation: a retrospective analysis.
    Zeng M; Yan X; Wu W
    BMC Cardiovasc Disord; 2021 Sep; 21(1):446. PubMed ID: 34535088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The adipokine vaspin is associated with decreased coronary in-stent restenosis in vivo and inhibits migration of human coronary smooth muscle cells in vitro.
    Kastl SP; Katsaros KM; Krychtiuk KA; Jägersberger G; Kaun C; Huber K; Wojta J; Speidl WS
    PLoS One; 2020; 15(5):e0232483. PubMed ID: 32392256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and risk factors of in-stent restenosis after percutaneous coronary intervention in patients from southern China.
    Li M; Hou J; Gu X; Weng R; Zhong Z; Liu S
    Eur J Med Res; 2022 Jan; 27(1):12. PubMed ID: 35065663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Research advances in CKLF-like MARVEL transmembrane domain containing member 5].
    Yuan YQ; Xiao YB; Liu ZH; Zhang XW; Xu T; Wang XF
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Dec; 34(6):625-8. PubMed ID: 23286412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of increased serum CTRP5 levels with in-stent restenosis after coronary drug-eluting stent implantation: CTRP5 promoting inflammation, migration and proliferation in vascular smooth muscle cells.
    Shen Y; Li C; Zhang RY; Zhang Q; Shen WF; Ding FH; Lu L
    Int J Cardiol; 2017 Feb; 228():129-136. PubMed ID: 27863353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High on-aspirin treatment platelet reactivity and restenosis after percutaneous coronary intervention: results of the Intracoronary Stenting and Antithrombotic Regimen-ASpirin and Platelet Inhibition (ISAR-ASPI) Registry.
    Mayer K; Ndrepepa G; Schroeter M; Emmer C; Bernlochner I; Schüpke S; Gewalt S; Hilz R; Coughlan JJ; Aytekin A; Heyken C; Morath T; Schunkert H; Laugwitz KL; Sibbing D; Kastrati A
    Clin Res Cardiol; 2023 Sep; 112(9):1231-1239. PubMed ID: 36786829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CMTM5 is reduced in prostate cancer and inhibits cancer cell growth in vitro and in vivo.
    Xiao Y; Yuan Y; Zhang Y; Li J; Liu Z; Zhang X; Sheng Z; Xu T; Wang X
    Clin Transl Oncol; 2015 Jun; 17(6):431-7. PubMed ID: 25387568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between fibrinogen-to-albumin ratio and in-stent restenosis in patients with coronary artery disease undergoing drug-eluting stenting.
    Chen T; Sun JL; Zhang J
    Coron Artery Dis; 2020 Nov; 31(7):586-589. PubMed ID: 32271235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Independent predictors of in-stent restenosis after drug-eluting stent implantation for ostial right coronary artery lesions.
    Watanabe Y; Takagi K; Naganuma T; Kawamoto H; Fujino Y; Ishiguro H; Tahara S; Kurita N; Hosawa K; Nakamura S; Nakamura S
    Int J Cardiol; 2017 Aug; 240():108-113. PubMed ID: 28476515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remnant Lipoprotein Cholesterol Independently Associates With In-Stent Restenosis After Drug-Eluting Stenting for Coronary Artery Disease.
    Xu X; Pandit RU; Han L; Li Y; Guo X
    Angiology; 2019 Oct; 70(9):853-859. PubMed ID: 31167539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes of plasma Rap1A levels in patients with in-stent restenosis after percutaneous coronary intervention and the underlying mechanisms.
    Gao H; Kuang Y; Liu Y; Zhang Y; Wang P; Ma Q
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Nov; 48(11):1650-1658. PubMed ID: 38432855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Abnormally lower expression of cmtm5 gene in bone marrow cells from patients with multiple myeloma].
    Niu JH; Bao L; Zhang Y; Li JL; Li LD; Xie M; Qin YZ; Lai YY; Jiang Q; Shi HL; Liu YR; Jiang B; Chen SS; Huang XJ; Ruan GR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Apr; 18(2):363-7. PubMed ID: 20416169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of high on-aspirin platelet reactivity on outcomes following successful percutaneous coronary intervention with drug-eluting stents.
    Chung CJ; Kirtane AJ; Zhang Y; Witzenbichler B; Weisz G; Stuckey TD; Brodie BR; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Mazzaferri EL; Mehran R; Stone GW
    Am Heart J; 2018 Nov; 205():77-86. PubMed ID: 30196181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of in-stent neointimal tissue components following drug-eluting stent implantation according to the phase of restenosis using a 40-MHz intravascular ultrasound imaging system.
    Araki T; Nakamura M; Sugi K
    J Cardiol; 2014 Dec; 64(6):423-9. PubMed ID: 24794755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.